0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Attention Deficit Hyperactivity Disorder Therapeutics Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-19S14381
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Attention Deficit Hyperactivity Disorder Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Attention Deficit Hyperactivity Disorder Therapeutics Market Research Report 2024

Code: QYRE-Auto-19S14381
Report
June 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Attention Deficit Hyperactivity Disorder Therapeutics Market Size

The global Attention Deficit Hyperactivity Disorder Therapeutics market was valued at US$ 13240 million in 2023 and is anticipated to reach US$ 18580 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Attention Deficit Hyperactivity Disorder Therapeutics Market

Attention Deficit Hyperactivity Disorder Therapeutics Market

Attention deficit hyperactivity disorder (ADHD) is a mental health disorder that can cause above-normal levels of hyperactive and impulsive behaviors.
The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics market is primarily driven by the increasing awareness and diagnosis of ADHD in both children and adults, leading to a demand for effective treatment options. ADHD therapeutics play a vital role in managing the symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily functioning, coupled with advancements in diagnostic criteria and increased mental health awareness, contributes to market growth. Moreover, developments in treatment modalities, including medication and behavioral interventions, further propel adoption. However, challenges include tailoring treatments to individual patient needs, addressing potential side effects of medications, and ensuring long-term treatment adherence. Navigating regulatory requirements, providing comprehensive behavioral therapy options, and combating stigma associated with ADHD are ongoing concerns. The market's success relies on continuous research into novel therapeutic approaches, collaborations between pharmaceutical companies and mental health professionals, and comprehensive public education on ADHD management while addressing the evolving challenges associated with diagnosis accuracy and multifaceted treatment strategies.
This report aims to provide a comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder Therapeutics.

Report Scope

The Attention Deficit Hyperactivity Disorder Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Attention Deficit Hyperactivity Disorder Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Attention Deficit Hyperactivity Disorder Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Attention Deficit Hyperactivity Disorder Therapeutics Market Report

Report Metric Details
Report Name Attention Deficit Hyperactivity Disorder Therapeutics Market
Accounted market size in 2023 US$ 13240 million
Forecasted market size in 2030 US$ 18580 million
CAGR 4.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Stimulant
  • Non-stimulant
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Attention Deficit Hyperactivity Disorder Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Attention Deficit Hyperactivity Disorder Therapeutics Market growing?

Ans: The Attention Deficit Hyperactivity Disorder Therapeutics Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Attention Deficit Hyperactivity Disorder Therapeutics Market size in 2030?

Ans: The Attention Deficit Hyperactivity Disorder Therapeutics Market size in 2030 will be US$ 18580 million.

Who are the main players in the Attention Deficit Hyperactivity Disorder Therapeutics Market report?

Ans: The main players in the Attention Deficit Hyperactivity Disorder Therapeutics Market are Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma

What are the Application segmentation covered in the Attention Deficit Hyperactivity Disorder Therapeutics Market report?

Ans: The Applications covered in the Attention Deficit Hyperactivity Disorder Therapeutics Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Attention Deficit Hyperactivity Disorder Therapeutics Market report?

Ans: The Types covered in the Attention Deficit Hyperactivity Disorder Therapeutics Market report are Stimulant, Non-stimulant

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Perspective (2019-2030)
2.2 Attention Deficit Hyperactivity Disorder Therapeutics Growth Trends by Region
2.2.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Attention Deficit Hyperactivity Disorder Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Attention Deficit Hyperactivity Disorder Therapeutics Market Dynamics
2.3.1 Attention Deficit Hyperactivity Disorder Therapeutics Industry Trends
2.3.2 Attention Deficit Hyperactivity Disorder Therapeutics Market Drivers
2.3.3 Attention Deficit Hyperactivity Disorder Therapeutics Market Challenges
2.3.4 Attention Deficit Hyperactivity Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Revenue
3.1.1 Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Attention Deficit Hyperactivity Disorder Therapeutics Revenue
3.4 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder Therapeutics Revenue in 2023
3.5 Attention Deficit Hyperactivity Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Attention Deficit Hyperactivity Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Attention Deficit Hyperactivity Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Attention Deficit Hyperactivity Disorder Therapeutics Breakdown Data by Type
4.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Type (2025-2030)
5 Attention Deficit Hyperactivity Disorder Therapeutics Breakdown Data by Application
5.1 Global Attention Deficit Hyperactivity Disorder Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2019-2030)
6.2 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024)
6.4 North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2019-2030)
7.2 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024)
7.4 Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2019-2030)
9.2 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma
11.5.1 Tris Pharma Company Detail
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.5.5 Tris Pharma Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Detail
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Detail
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Detail
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Detail
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Detail
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder Therapeutics Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
11.10.5 Purdue Parma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Stimulant
    Table 3. Key Players of Non-stimulant
    Table 4. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Region (2025-2030)
    Table 10. Attention Deficit Hyperactivity Disorder Therapeutics Market Trends
    Table 11. Attention Deficit Hyperactivity Disorder Therapeutics Market Drivers
    Table 12. Attention Deficit Hyperactivity Disorder Therapeutics Market Challenges
    Table 13. Attention Deficit Hyperactivity Disorder Therapeutics Market Restraints
    Table 14. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Players (2019-2024)
    Table 16. Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder Therapeutics as of 2023)
    Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Attention Deficit Hyperactivity Disorder Therapeutics Product Solution and Service
    Table 21. Date of Enter into Attention Deficit Hyperactivity Disorder Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Application (2019-2024)
    Table 29. Global Attention Deficit Hyperactivity Disorder Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Attention Deficit Hyperactivity Disorder Therapeutics Revenue Market Share by Application (2025-2030)
    Table 31. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Takeda Company Detail
    Table 47. Takeda Business Overview
    Table 48. Takeda Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 49. Takeda Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 50. Takeda Recent Development
    Table 51. Johnson & Johnson Company Detail
    Table 52. Johnson & Johnson Business Overview
    Table 53. Johnson & Johnson Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 54. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 55. Johnson & Johnson Recent Development
    Table 56. Novartis Company Detail
    Table 57. Novartis Business Overview
    Table 58. Novartis Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 59. Novartis Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 60. Novartis Recent Development
    Table 61. Eli Lilly Company Detail
    Table 62. Eli Lilly Business Overview
    Table 63. Eli Lilly Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 64. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 65. Eli Lilly Recent Development
    Table 66. Tris Pharma Company Detail
    Table 67. Tris Pharma Business Overview
    Table 68. Tris Pharma Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 69. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 70. Tris Pharma Recent Development
    Table 71. Neos Therapeutics Company Detail
    Table 72. Neos Therapeutics Business Overview
    Table 73. Neos Therapeutics Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 74. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 75. Neos Therapeutics Recent Development
    Table 76. Mallinckrodt Company Detail
    Table 77. Mallinckrodt Business Overview
    Table 78. Mallinckrodt Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 79. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 80. Mallinckrodt Recent Development
    Table 81. Amneal Pharmaceuticals Company Detail
    Table 82. Amneal Pharmaceuticals Business Overview
    Table 83. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 85. Amneal Pharmaceuticals Recent Development
    Table 86. Noven Pharmaceuticals Company Detail
    Table 87. Noven Pharmaceuticals Business Overview
    Table 88. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 89. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 90. Noven Pharmaceuticals Recent Development
    Table 91. Purdue Parma Company Detail
    Table 92. Purdue Parma Business Overview
    Table 93. Purdue Parma Attention Deficit Hyperactivity Disorder Therapeutics Product
    Table 94. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024) & (US$ Million)
    Table 95. Purdue Parma Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Stimulant Features
    Figure 4. Non-stimulant Features
    Figure 5. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Pharmacy Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Attention Deficit Hyperactivity Disorder Therapeutics Report Years Considered
    Figure 10. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Region: 2023 VS 2030
    Figure 13. Global Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Players in 2023
    Figure 14. Global Top Attention Deficit Hyperactivity Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder Therapeutics as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder Therapeutics Revenue in 2023
    Figure 16. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2019-2030)
    Figure 18. United States Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2019-2030)
    Figure 22. Germany Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Region (2019-2030)
    Figure 30. China Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2019-2030)
    Figure 38. Mexico Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Attention Deficit Hyperactivity Disorder Therapeutics Market Share by Country (2019-2030)
    Figure 42. Turkey Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Attention Deficit Hyperactivity Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 45. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 46. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 47. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 48. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 49. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 50. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 51. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 52. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 53. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder Therapeutics Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Infantile Spasm Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29V5838
Mon Jul 08 00:00:00 UTC 2024

Add to Cart

Global Spinal Cord Injury Therapeutic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34T13315
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Neurology Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32U11385
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Relapsing Multiple Sclerosis Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32N5658
Tue Jun 18 00:00:00 UTC 2024

Add to Cart